2024-11-19 09:19:50
CStone Pharmaceuticals Announces China's NMPA has Accepted its New Drug Application for anti-PD-L1 Monoclonal Antibody Sugemalimab in First-Line Advanced NSCLC
Corporate/ 2023-07-23
CStone Pharmaceuticals Announces China&#...

Currently,there is no anti-PD-L1 monoclonal antibody approved for stage IV NSCLC in China An oral presentation of specific clinical trial da...

Farrer Park Hospital Steps Up Prostate Cancer Treatment with Lutetium-177 PSMA Therapy
Health/ 2023-07-22
Farrer Park Hospital Steps Up Prostate C...

SINGAPORE,Nov. 10,2020--Farrer Park Hospital announced today the availability of Lutetium-177 Prostate Specific Membrane Antigen Therapy (&q...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release